Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Axogen Inc (AXGN) vs Huntington Ingalls Industries Inc (HII) Price & Performance

Axogen IncTrade
Huntington Ingalls Industries IncTrade

Price performance (Past 24H)

Key statistics

Axogen Inc vs Huntington Ingalls Industries Inc — how do they compare? Axogen Inc trades at $38.6 (market cap $2.06B), while Huntington Ingalls Industries Inc trades at $282.25 (market cap $11.03B). The key difference: Huntington Ingalls Industries Inc is far larger — about 5.4× Axogen Inc's market cap, and Huntington Ingalls Industries Inc pays a 1.97% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.

AXGNHII
Market Cap
$2.06B$11.03B
Sector
TechnologyTechnology
52-Week High
$46.19$453.73
52-Week Low
$11.28$252.93
Enterprise Value
$1.98B$13.75B
Dividend Yield
1.97%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Axogen Inc

AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.

The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.

Huntington Ingalls Industries Inc

HII trades at $284.86, down 0.43% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company shows stable fundamentals with a P/E of 18.19 and net income margin of 4.71%, supported by recent earnings beats. Recent news highlights contract awards and leadership additions, reinforcing its defense sector presence.

The outlook is cautiously optimistic with a consensus price target of $354.50, implying significant upside. Risks include execution on new contracts and defense budget dependencies, but analyst sentiment leans positive with 44% buy ratings. The upcoming Q2 2026 earnings report on July 30 will be a key catalyst for near-term direction.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Axogen Inc

Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.

Read more on AXGN

About Huntington Ingalls Industries Inc

Huntington Ingalls is the largest military shipbuilder in the U.S. and a provider of professional services to government and industry partners, specializing in nuclear-powered submarines and aircraft carriers.

Read more on HII